Link to article on investing.com: https://www.investing.com/analysis/why-investors-should-track-the-prescription-drug-user-fee-act-200583708
Summary:
DUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the US Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market. Among the dozens of corporate event data points provided to our customers, Wall Street Horizon gathers PDUFA dates and content so our clients stay in the know.
Recent Content
-
.png)
Mid-Quarter Investor Conference Calendar: Stocks Heat Up Heading Into Autumn
-
12.png)
Earnings Signals & Labor Slowdowns: Testing the Limits of Consumer Resilience
-
.png)
From Classrooms to Wall Street: Why Back-to-School Matters More This Year
-
.png)
Divided Tech, Divided Fed: Navigating AI Capex Scrutiny and Mixed Macro Signals
-
.png)
AI Capex Hits a Tipping Point as Investors Demand More Corporate Discipline
-
.png)
The AI Capex Warning: Alphabet Sets a Tense Stage for Amazon, Microsoft, and Meta
-
.png)
Mild Macro Data Sets up AI Tech Earnings and a Busy August Corporate Event Stretch
-
.png)
A Stellar Start: Big Banks Defy Credit Fears to Kick Off Q2 Earnings
-
.png)
SaaSpocalypse Part II? IBM’s Preliminary Earnings Report Rattles Software
-
.png)
Q2 2026 Earnings Preview: Navigating High Expectations, Tariff Rebates, and War Uncertainties
